Intellia Therapeutics Insider Trades

NTLA

Track insider trading activity from Intellia Therapeutics executives and directors. See which insiders are buying and selling NTLA stock.

Trades Last 12 Months

NTLA Price

All Insider Trades for Intellia Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dulac Edward J Iii Evp, Chief Financial Officer
Holding Value $2.08M 156,286 shares
Last Trade
Jul 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$84.2k 4,677 shares
$18.00
$13.30
Dube Michael P Vp, Chief Accounting Officer
Holding Value $890k 66,886 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$44.3k 2,641 shares
$16.78
$13.30
Keresty Georgia Director
Holding Value $546k 41,083 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.30
Cohen Fred E Director
Holding Value $2.88M 216,653 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.30
Bhanji Muna Director
Holding Value $484k 36,403 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.30
Goff Brian Director
Holding Value $434k 32,609 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.30
Goodman Jesse Director
Holding Value $446k 33,559 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.30
Verwiel Frank Director
Holding Value $467k 35,148 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.30
Chase William J Director
Holding Value $1.91M 143,893 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.30
Clark Eliana Evp, Chief Technical Officer
Holding Value $1.25M 93,864 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.37k 607 shares
$15.44
$13.30
Basta James Evp, General Counsel
Holding Value $2.09M 156,794 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.7k 1,211 shares
$15.44
$13.30
Lebwohl David Evp, Chief Medical Officer
Holding Value $1.74M 131,192 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$333k 24,147 shares
$13.78
$13.30
Schultes Birgit C Evp, Chief Scientific Officer
Holding Value $1.83M 137,733 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 95,200 shares
$13.78
$13.30
Leonard John M President And CEO
Holding Value $15.6M 1,169,739 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.16M 156,400 shares
$13.78
$13.30
Dulac Edward J Iii Evp, Chief Financial Officer
Holding Value $2.14M 160,963 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$844k 61,280 shares
$13.78
$13.30
Chase William J Director
Holding Value $1.79M 134,693 shares
Last Trade
Aug 20, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1M 100,000 shares
$10.03
$13.30
Goodman Jesse Director
Holding Value $324k 24,359 shares
Last Trade
Jul 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.3k 1,547 shares
$9.23
$13.30
Sepp Lorenzino Laura Evp, Chief Scientific Officer
Holding Value $1.03M 77,388 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$109k 8,966 shares
$12.18
$13.30
Hicks Derek Evp, Chief Business Officer
Holding Value $796k 59,878 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$79.2k 6,502 shares
$12.18
$13.30
Goddard Glenn Evp, Chief Financial Officer
Holding Value $921k 69,213 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 41,316 shares
$32.66
$13.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up